
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ongoing Clinical Trials of Nonviral siRNA Therapeutics
Eshan A. Narasipura, Rachel VanKeulen-Miller, Yutian Ma, et al.
Bioconjugate Chemistry (2023) Vol. 34, Iss. 7, pp. 1177-1197
Closed Access | Times Cited: 41
Eshan A. Narasipura, Rachel VanKeulen-Miller, Yutian Ma, et al.
Bioconjugate Chemistry (2023) Vol. 34, Iss. 7, pp. 1177-1197
Closed Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
Inflammasome components as new therapeutic targets in inflammatory disease
Rebecca C. Coll, Kate Schroder
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 21
Rebecca C. Coll, Kate Schroder
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 21
A perspective of lipid nanoparticles for RNA delivery
Yutian Ma, Shiyao Li, Xin Lin, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 17
Yutian Ma, Shiyao Li, Xin Lin, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 17
Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities
Houman Isazadeh, Farshid Oruji, Shima Shabani, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 11, pp. 9529-9543
Closed Access | Times Cited: 31
Houman Isazadeh, Farshid Oruji, Shima Shabani, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 11, pp. 9529-9543
Closed Access | Times Cited: 31
Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies
Pu-Sheng Wei, Nagasri Thota, Gresham John, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 366-388
Open Access | Times Cited: 13
Pu-Sheng Wei, Nagasri Thota, Gresham John, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 366-388
Open Access | Times Cited: 13
Controlled enzymatic synthesis of oligonucleotides
Maëva Pichon, Marcel Hollenstein
Communications Chemistry (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 12
Maëva Pichon, Marcel Hollenstein
Communications Chemistry (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 12
Therapeutic synthetic and natural materials for immunoengineering
Anna Slezak, Kevin Chang, Samir Hossainy, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 4, pp. 1789-1822
Open Access | Times Cited: 11
Anna Slezak, Kevin Chang, Samir Hossainy, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 4, pp. 1789-1822
Open Access | Times Cited: 11
Optimization of lipid assisted polymeric nanoparticles for siRNA delivery and cancer immunotherapy
Song Lin, Houjin Jing, Xiao‐Jiao Du, et al.
Biomaterials Science (2024) Vol. 12, Iss. 8, pp. 2057-2066
Closed Access | Times Cited: 8
Song Lin, Houjin Jing, Xiao‐Jiao Du, et al.
Biomaterials Science (2024) Vol. 12, Iss. 8, pp. 2057-2066
Closed Access | Times Cited: 8
Expanding RNAi to Kidneys, Lungs, and Spleen via Selective ORgan Targeting (SORT) siRNA Lipid Nanoparticles
Amogh Vaidya, Stephen D. Moore, Sumanta Chatterjee, et al.
Advanced Materials (2024) Vol. 36, Iss. 35
Closed Access | Times Cited: 8
Amogh Vaidya, Stephen D. Moore, Sumanta Chatterjee, et al.
Advanced Materials (2024) Vol. 36, Iss. 35
Closed Access | Times Cited: 8
Bioinspired Spatiotemporal Management toward RNA Therapies
Yutian Ma, Shiyao Li, Xin Lin, et al.
ACS Nano (2023) Vol. 17, Iss. 24, pp. 24539-24563
Closed Access | Times Cited: 13
Yutian Ma, Shiyao Li, Xin Lin, et al.
ACS Nano (2023) Vol. 17, Iss. 24, pp. 24539-24563
Closed Access | Times Cited: 13
Inorganic nanocarriers for siRNA delivery for cancer treatments
Ganeshlenin Kandasamy, Dipak Maity
Biomedical Materials (2024) Vol. 19, Iss. 2, pp. 022001-022001
Open Access | Times Cited: 5
Ganeshlenin Kandasamy, Dipak Maity
Biomedical Materials (2024) Vol. 19, Iss. 2, pp. 022001-022001
Open Access | Times Cited: 5
Advances in non-viral mRNA delivery to the spleen
Eshan A. Narasipura, Owen S. Fenton
Biomaterials Science (2024) Vol. 12, Iss. 12, pp. 3027-3044
Closed Access | Times Cited: 5
Eshan A. Narasipura, Owen S. Fenton
Biomaterials Science (2024) Vol. 12, Iss. 12, pp. 3027-3044
Closed Access | Times Cited: 5
Polyphenolic Nanoparticle Platforms (PARCELs) for In Vitro and In Vivo mRNA Delivery
Yutian Ma, Palas B. Tiwade, Rachel VanKeulen-Miller, et al.
Nano Letters (2024) Vol. 24, Iss. 20, pp. 6092-6101
Open Access | Times Cited: 5
Yutian Ma, Palas B. Tiwade, Rachel VanKeulen-Miller, et al.
Nano Letters (2024) Vol. 24, Iss. 20, pp. 6092-6101
Open Access | Times Cited: 5
TRIM25: A Global Player of Cell Death Pathways and Promising Target of Tumor-Sensitizing Therapies
W. Eberhardt, Usman Nasrullah, Josef Pfeilschifter
Cells (2025) Vol. 14, Iss. 2, pp. 65-65
Open Access
W. Eberhardt, Usman Nasrullah, Josef Pfeilschifter
Cells (2025) Vol. 14, Iss. 2, pp. 65-65
Open Access
mRNA lipid nanoparticle formulation, characterization and evaluation
Yutian Ma, Rachel VanKeulen-Miller, Owen S. Fenton
Nature Protocols (2025)
Closed Access
Yutian Ma, Rachel VanKeulen-Miller, Owen S. Fenton
Nature Protocols (2025)
Closed Access
Ionic Coating of siRNA Polyplexes with cRGD–PEG–Hyaluronic Acid To Modulate Serum Stability and In Vivo Performance
Victoria C. Vetter, Mina Yazdi, Irene Gialdini, et al.
Biochemistry (2025)
Closed Access
Victoria C. Vetter, Mina Yazdi, Irene Gialdini, et al.
Biochemistry (2025)
Closed Access
Non-Viral RNA Therapies for Non-Small Cell Lung Cancer and Their Corresponding Clinical Trials
Palas Balakdas Tiwade, Vincent Fung, Rachel VanKeulen-Miller, et al.
Molecular Pharmaceutics (2025)
Closed Access
Palas Balakdas Tiwade, Vincent Fung, Rachel VanKeulen-Miller, et al.
Molecular Pharmaceutics (2025)
Closed Access
PEG-ASO conjugates for efficient targeted delivery and migration inhibition in Cancer cell
Chunhui Zhao, Xiangjun Li, Zixin He, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130208-130208
Closed Access
Chunhui Zhao, Xiangjun Li, Zixin He, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130208-130208
Closed Access
The Fomivirsen, Patisiran, and Givosiran Odyssey: How the Success Stories May Pave the Way for Future Clinical Translation of Nucleic Acid Drugs
Mona Mansouri, Kimia Mansouri, Zahra Taheri, et al.
BioDrugs (2025)
Closed Access
Mona Mansouri, Kimia Mansouri, Zahra Taheri, et al.
BioDrugs (2025)
Closed Access
Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunities
Kailash Ahirwar, Ankit Kumar, Nidhi Srivastava, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 131048-131048
Closed Access | Times Cited: 4
Kailash Ahirwar, Ankit Kumar, Nidhi Srivastava, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 131048-131048
Closed Access | Times Cited: 4
Technologies for Targeted RNA Degradation and Induced RNA Decay
Sigitas Mikutis, Gonçalo J. L. Bernardes
Chemical Reviews (2024)
Open Access | Times Cited: 4
Sigitas Mikutis, Gonçalo J. L. Bernardes
Chemical Reviews (2024)
Open Access | Times Cited: 4
Assessment of the Efficacy of the Combination of RNAi of lncRNA DANCR with Chemotherapy to Treat Triple Negative Breast Cancer Using Magnetic Resonance Molecular Imaging
Calin Nicolescu, Jiyoon Kim, Da Sun, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 3, pp. 381-388
Closed Access | Times Cited: 3
Calin Nicolescu, Jiyoon Kim, Da Sun, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 3, pp. 381-388
Closed Access | Times Cited: 3
Fluorescent Techniques for RNA Detection in Nanoparticles
Simone Pinto Carneiro, Joschka T Müller, Olivia M. Merkel
Methods in molecular biology (2024), pp. 187-203
Closed Access | Times Cited: 3
Simone Pinto Carneiro, Joschka T Müller, Olivia M. Merkel
Methods in molecular biology (2024), pp. 187-203
Closed Access | Times Cited: 3
Precision arrows: Navigating breast cancer with nanotechnology siRNA
Nandani Jayaswal, Shriyansh Srivastava, Sachin Kumar, et al.
International Journal of Pharmaceutics (2024) Vol. 662, pp. 124403-124403
Closed Access | Times Cited: 3
Nandani Jayaswal, Shriyansh Srivastava, Sachin Kumar, et al.
International Journal of Pharmaceutics (2024) Vol. 662, pp. 124403-124403
Closed Access | Times Cited: 3
Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs
Daigo Asano, Hideo Takakusa, Daisuke Nakai
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 47-47
Open Access | Times Cited: 8
Daigo Asano, Hideo Takakusa, Daisuke Nakai
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 47-47
Open Access | Times Cited: 8
4′-C-Acetamidomethyl-2′-O-methoxyethyl Nucleic Acid Modifications Improve Thermal Stability, Nuclease Resistance, Potency, and hAgo2 Binding of Small Interfering RNAs
Sumit Gangopadhyay, Gourav Das, Shalini Gupta, et al.
The Journal of Organic Chemistry (2024) Vol. 89, Iss. 6, pp. 3747-3768
Closed Access | Times Cited: 2
Sumit Gangopadhyay, Gourav Das, Shalini Gupta, et al.
The Journal of Organic Chemistry (2024) Vol. 89, Iss. 6, pp. 3747-3768
Closed Access | Times Cited: 2